ClearPoint Neuro, Inc.

12.60+0.8900+7.60%Vol 2.11M1Y Perf -41.39%
Jun 24th, 2022 16:00 DELAYED
BID11.94 ASK12.60
Open11.88 Previous Close11.71
Pre-Market- After-Market12.60
 - -  - -%
Target Price
15.00 
Analyst Rating
Strong Buy 1.00
Potential %
19.05 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     48.86
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     46.19
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
35.44 
Earnings Rating
Market Cap198.21M 
Earnings Date
9th Aug 2022
Alpha0.03 Standard Deviation0.21
Beta1.25 

Today's Price Range

11.8512.71

52W Range

7.0022.80

5 Year PE Ratio Range

-24.80-2.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
29.23%
1 Month
29.76%
3 Months
35.05%
6 Months
7.14%
1 Year
-41.39%
3 Years
306.45%
5 Years
250.00%
10 Years
-76.49%

TickerPriceChg.Chg.%
CLPT12.600.89007.60
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
13.10
14.60
0.20
0.27
-20.20
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
68.90
-87.20
-85.90
-76.00
-91.51
RevenueValueIndustryS&P 500US Markets
17.30M
1.10
22.25
21.19
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.20-0.1715.00
Q04 2021--0.19-
Q03 2021--0.18-
Q02 2021-0.14-0.17-21.43
Q01 2021-0.15-0.1313.33
Q04 2020-0.13-0.0930.77
Q03 2020-0.14-0.0935.71
Q02 2020-0.16-0.1131.25
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Aug 2022
Estimated EPS Next Report-0.18
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.11M
Shares Outstanding15.73K
Shares Float21.91M
Trades Count6.61K
Dollar Volume26.45M
Avg. Volume188.36K
Avg. Weekly Volume202.37K
Avg. Monthly Volume167.97K
Avg. Quarterly Volume194.75K

ClearPoint Neuro, Inc. (NASDAQ: CLPT) stock closed at 12.6 per share at the end of the most recent trading day (a 7.6% change compared to the prior day closing price) with a volume of 2.11M shares and market capitalization of 198.21M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 38 people. ClearPoint Neuro, Inc. CEO is Joseph M. Burnett.

The one-year performance of ClearPoint Neuro, Inc. stock is -41.39%, while year-to-date (YTD) performance is 12.3%. CLPT stock has a five-year performance of 250%. Its 52-week range is between 7 and 22.8, which gives CLPT stock a 52-week price range ratio of 35.44%

ClearPoint Neuro, Inc. currently has a PE ratio of -13.70, a price-to-book (PB) ratio of 5.06, a price-to-sale (PS) ratio of 8.87, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -23.28%, a ROC of -23.36% and a ROE of -35.29%. The company’s profit margin is -91.51%, its EBITDA margin is -85.90%, and its revenue ttm is $17.30 Million , which makes it $1.10 revenue per share.

Of the last four earnings reports from ClearPoint Neuro, Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.18 for the next earnings report. ClearPoint Neuro, Inc.’s next earnings report date is 09th Aug 2022.

The consensus rating of Wall Street analysts for ClearPoint Neuro, Inc. is Strong Buy (1), with a target price of $15, which is +19.05% compared to the current price. The earnings rating for ClearPoint Neuro, Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ClearPoint Neuro, Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ClearPoint Neuro, Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 23.44, ATR14 : 0.89, CCI20 : 148.87, Chaikin Money Flow : 0.35, MACD : 0.35, Money Flow Index : 78.63, ROC : 3.58, RSI : 63.90, STOCH (14,3) : 96.64, STOCH RSI : 1.00, UO : 61.93, Williams %R : -3.36), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ClearPoint Neuro, Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

ClearPoint Neuro, Inc.

MRI Interventions Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint Neuro Intervention System and The ClearTrace Cardiac Intervention System.

CEO: Joseph M. Burnett

Telephone: +1 949 900-6833

Address: 5 Musick, Irvine 92618, CA, US

Number of employees: 38

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

54%46%

Bearish Bullish

50%50%

TipRanks News for CLPT

Mon, 09 May 2022 06:45 GMT ClearPoint Neuro (CLPT) Receives a Buy from B.Riley Financial

- TipRanks. All rights reserved.

News

Stocktwits